Literature DB >> 22056954

Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia.

Pelin Bagci1, Aleodor A Andea, Olca Basturk, Kee-Taek Jang, Ipek Erbarut, Volkan Adsay.   

Abstract

A morphological variant of pancreatic ductal adenocarcinoma forming large ductal elements, large duct type ductal adenocarcinoma, is documented and its clinicopathological features are studied. These tumors may have microcystic and papillary growth patterns that closely mimic the non-invasive cystic and papillary pancreatic tumors such as: intraductal papillary-mucinous neoplasia, including the oncocytic variant, mucinous cystic neoplasms, and ducts involved by pancreatic intraepithelial neoplasia. In a review of 230 pancreatectomy specimens with ductal adenocarcinoma, 28 (8%) cases of large duct type ductal adenocarcinomas were identified according to following criteria: more than 50% of the tumor sections available for examination contained infiltrative ducts with a diameter larger than 0.5 mm or had a macroscopically identifiable microcystic pattern. Overall characteristics of large duct type ductal adenocarcinomas were not too different than those of conventional ductal adenocarcinomas, except that there was a slight female predominance in the former (F/M=2.3). The mean age was 67 (vs 63 in conventional ductal adenocarcinomas; P=0.015), and occurrence in the tail was slightly more common (40% vs 18% in conventional ductal adenocarcinomas; P=0.006). Grossly, cysts measuring up to 1 cm was noted in 10 cases. Microscopically, large duct type adenocarcinomas were characterized by irregularly distributed large ducts with jagged edges, lined by columnar mucinous cells often having deceptively bland cytological features and variable degrees of papillomatosis. Stromal desmoplasia had a hypercellular quality (morphologically distinct from ovarian-like stroma) in four cases, and had a myxoid quality in others. KRAS oncogene mutation was identified in 9 out of 11 cases. Median, 1-year and 2-year survival rates were 16 months, 77% and 30%, respectively, as opposed to 12 months, 52% and 30%, respectively, in conventional ductal adenocarcinoma. In conclusion, it should be recognized that, some (8%) pancreatic ductal adenocarcinomas exhibit a large duct pattern that may microscopically mimic non-invasive pancreatic tumors characterized by cystic and papillary patterns. They may be distinguished by the relatively smaller size of the cysts, irregularity of the duct contours, clustering of the ducts, presence of intraluminal neutrophils and granular debris, degree of cytological pleomorphism, and myxoid quality of the stroma. Clinical behavior appears to be slightly better than that of conventional ductal adenocarcinoma, which may be accounted by the well-differentiated nature of these tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056954     DOI: 10.1038/modpathol.2011.181

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

Review 1.  Pancreas ductal adenocarcinoma with cystic features on cross-sectional imaging: radiologic-pathologic correlation.

Authors:  Seo Yeon Youn; Sung Eun Rha; Eun Sun Jung; In Seok Lee
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

Review 2.  Differentiation of mucinous cystic neoplasm and cystic changes associated with pancreatic adenocarcinoma.

Authors:  Tae Hwan Ha; Tae Joo Jeon; Ji Young Park
Journal:  BMJ Case Rep       Date:  2013-11-05

3.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 4.  Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Authors:  Daniel Åkerberg; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

5.  Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma.

Authors:  Shutaro Hori; Kazuaki Shimada; Yoshinori Ino; Seiji Oguro; Minoru Esaki; Satoshi Nara; Yoji Kishi; Tomoo Kosuge; Yukinori Hattori; Aoi Sukeda; Yuko Kitagawa; Yae Kanai; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-10-05       Impact factor: 4.064

6.  Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.

Authors:  Takashi Muraki; Kee-Taek Jang; Michelle D Reid; Burcin Pehlivanoglu; Bahar Memis; Olca Basturk; Pardeep Mittal; David Kooby; Shishir K Maithel; Juan M Sarmiento; Kathleen Christians; Susan Tsai; Douglas Evans; Volkan Adsay
Journal:  Mod Pathol       Date:  2021-09-13       Impact factor: 7.842

7.  Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.

Authors:  Michelle D Reid; Christina R Stallworth; Melinda M Lewis; Gizem Akkas; Bahar Memis; Olca Basturk; Volkan Adsay
Journal:  Cancer Cytopathol       Date:  2015-09-28       Impact factor: 5.284

Review 8.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

Review 9.  Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers.

Authors:  Jiandong Wu; Meili Dong; Susy Santos; Claudio Rigatto; Yong Liu; Francis Lin
Journal:  Sensors (Basel)       Date:  2017-12-17       Impact factor: 3.576

10.  Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection.

Authors:  Lianhua Dong; Shangjun Wang; Boqiang Fu; Jing Wang
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.